CompletedNot applicableNCT00022035

Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Roswell Park Cancer Institute
Principal Investigator
Martin L. Brecher, MD
Roswell Park Cancer Institute
Intervention
trivalent influenza vaccine(biological)
Eligibility
1-20 years · All sexes
Timeline
2000

Study locations (2)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00022035 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials